Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example EvidenceVariable/example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort (XML)

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

Raw XML (canonical form + also see XML Format Specification)

Jump past Narrative

Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis (id = "example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort")

<?xml version="1.0" encoding="UTF-8"?>

<EvidenceVariable xmlns="http://hl7.org/fhir">
  <id value="example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort"/> 
  <text> 
    <status value="generated"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      
      <p> 
      Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual
         patient data meta-analysis
      </p> 
    
    </div> 
  </text> 
  <name value="StrokeThrombolysisTrialists20142016IPDMACohort"/> 
  <title value="Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual
   patient data meta-analysis"/> 
  <status value="draft"/> 
  <description value="Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual
   patient data meta-analysis"/> 
  <relatedArtifact> 
    <type value="citation"/> 
    <label value="Emberson 2014"/> 
    <display value="Effect of treatment delay, age, and stroke severity on the effects of intravenous
     thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual
     patient data from randomised trials."/> 
    <citation value="Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis
     Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity
     on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke:
     a meta-analysis of individual patient data from randomised trials. Lancet 2014
     Nov 29;384(9958):1929-35 PMID 25106063"/> 
    <document> 
      <url value="https://doi.org/10.1016/S0140-6736(14)60584-5"/> 
    </document> 
  </relatedArtifact> 
  <relatedArtifact> 
    <type value="citation"/> 
    <label value="Lees 2016"/> 
    <display value="Figure 2 Lees 2016"/> 
    <citation value="Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke
     Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke
     on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke.
     2016;47:2373-2379. PMID 27507856"/> 
    <document> 
      <url value="https://doi.org/10.1161/STROKEAHA.116.013644"/> 
    </document> 
  </relatedArtifact> 
  <actual value="true"/> 
  <characteristic> 
    <description value="Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual
     patient data meta-analysis"/> 
    <definitionByCombination> 
      <code value="any-of"/> 
      <characteristic> 
        <definitionReference> 
          <reference value="Group/ECASSIII-Trial-Cohort"/> 
          <type value="Group"/> 
          <display value="ECASS III Trial Cohort"/> 
        </definitionReference> 
      </characteristic> 
      <characteristic> 
        <definitionReference> 
          <reference value="Group/IST3-Trial-Cohort"/> 
          <type value="Group"/> 
          <display value="IST3 Trial Cohort"/> 
        </definitionReference> 
      </characteristic> 
      <characteristic> 
        <definitionReference> 
          <reference value="Group/ECASS-Trial-Cohort"/> 
          <type value="Group"/> 
          <display value="ECASS Trial Cohort"/> 
        </definitionReference> 
      </characteristic> 
      <characteristic> 
        <definitionReference> 
          <reference value="Group/ECASSII-Trial-Cohort"/> 
          <type value="Group"/> 
          <display value="ECASSII Trial Cohort"/> 
        </definitionReference> 
      </characteristic> 
      <characteristic> 
        <definitionReference> 
          <reference value="Group/EPITHET-Trial-Cohort"/> 
          <type value="Group"/> 
          <display value="EPITHET Trial Cohort"/> 
        </definitionReference> 
      </characteristic> 
      <characteristic> 
        <definitionReference> 
          <reference value="Group/ATLANTIS-Trial-Cohort"/> 
          <type value="Group"/> 
          <display value="ATLANTIS Trial Cohort"/> 
        </definitionReference> 
      </characteristic> 
      <characteristic> 
        <definitionReference> 
          <reference value="Group/NINDS-Trial-Cohort"/> 
          <type value="Group"/> 
          <display value="NINDS Trial Cohort"/> 
        </definitionReference> 
      </characteristic> 
    </definitionByCombination> 
  </characteristic> 
</EvidenceVariable> 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.